Skip to content

XERIS BIOPHARMA HOLDINGS, INC.: filings

Every XERIS BIOPHARMA HOLDINGS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 20 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026501380001867096-26-000065
10-Q2026-05-07fiscal Q1 2026511060001867096-26-000030
10-K2026-03-02fiscal FY 2025531370001867096-26-000016
10-Q2025-11-06fiscal Q3 2025521480001867096-25-000159
10-Q2025-08-07fiscal Q2 2025511410001867096-25-000136
10-Q2025-05-08fiscal Q1 2025511060001867096-25-000089
10-K2025-03-06fiscal FY 2024541370001867096-25-000039
10-Q2024-11-08fiscal Q3 2024521460001867096-24-000187
10-Q2024-08-08fiscal Q2 2024521420001867096-24-000162
10-Q2024-05-09fiscal FY 2024521080001867096-24-000065
10-K2024-03-06fiscal FY 2023541360001867096-24-000031
10-Q2023-11-09fiscal Q3 2023521460001867096-23-000139
10-Q2023-08-08fiscal FY 2023521420001867096-23-000114
10-Q2023-05-09fiscal FY 2023521080001867096-23-000069
10-K2023-03-08fiscal FY 2022531060001867096-23-000031
10-Q2022-11-09fiscal Q3 2022491380001867096-22-000127
10-Q2022-08-10fiscal Q2 2022481310001867096-22-000107
10-Q2022-05-11fiscal Q1 2022491010001867096-22-000063
10-K2022-03-11fiscal FY 202145910001867096-22-000040
10-Q2021-11-10fiscal Q3 2021391120001867096-21-000069

Inspect the source

Entity
XERIS BIOPHARMA HOLDINGS, INC. / CIK 0001867096
Captured
2026-09-21T17:39:39.343Z
SEC response SHA-256
a82bc6c68d522af16d0a90951a4c3b7347e59e7d5c2ae270c5647e888d58673f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001867096.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))